An investigation of the potential clinical utility of critical slowing down as an early warning sign for recurrence of depression.

Complex dynamic systems Critical slowing down Depression Early warning signs Ecological momentary assessment Relapse

Journal

Journal of behavior therapy and experimental psychiatry
ISSN: 1873-7943
Titre abrégé: J Behav Ther Exp Psychiatry
Pays: Netherlands
ID NLM: 0245075

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 06 09 2022
revised: 06 10 2023
accepted: 25 10 2023
medline: 4 12 2023
pubmed: 13 11 2023
entrez: 13 11 2023
Statut: ppublish

Résumé

Much of the burden of depressive illness is due to relapses that occur after treatment into remission. Prediction of an individual's imminent depressive relapse could lead to just-in-time interventions to prevent relapse, reducing depression's substantial burden of disability, costs, and suicide risk. Increasingly strong relationships in the form of autocorrelations between depressive symptoms, a signal of a phenomenon described as critical slowing down (CSD), have been proposed as a means of predicting relapse. In the current study, four participants in remission from depression, one of whom relapsed, responded to daily smartphone surveys with depression symptoms. We used p-technique factor analysis to identify depression factors from over 100 survey responses. We then tested for the presence of CSD using time-varying vector autoregression and detrended fluctuation analysis. We found evidence that CSD provided an early warning sign for depression in the participant who relapsed, but we also detected false positive indications of CSD in participants who did not relapse. Results from time-varying vector autoregression and detrended fluctuation analysis were not in agreement. Limitations include use of secondary data and a small number of participants with daily responding to a subset of depression symptoms. CSD provides a compelling framework for predicting depressive relapse and future research should focus on improving detection of early warning signs reliably. Improving early detection methods for depression is clinically significant, as it would allow for the development of just-in-time interventions.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
Much of the burden of depressive illness is due to relapses that occur after treatment into remission. Prediction of an individual's imminent depressive relapse could lead to just-in-time interventions to prevent relapse, reducing depression's substantial burden of disability, costs, and suicide risk. Increasingly strong relationships in the form of autocorrelations between depressive symptoms, a signal of a phenomenon described as critical slowing down (CSD), have been proposed as a means of predicting relapse.
METHODS METHODS
In the current study, four participants in remission from depression, one of whom relapsed, responded to daily smartphone surveys with depression symptoms. We used p-technique factor analysis to identify depression factors from over 100 survey responses. We then tested for the presence of CSD using time-varying vector autoregression and detrended fluctuation analysis.
RESULTS RESULTS
We found evidence that CSD provided an early warning sign for depression in the participant who relapsed, but we also detected false positive indications of CSD in participants who did not relapse. Results from time-varying vector autoregression and detrended fluctuation analysis were not in agreement.
LIMITATIONS CONCLUSIONS
Limitations include use of secondary data and a small number of participants with daily responding to a subset of depression symptoms.
CONCLUSIONS CONCLUSIONS
CSD provides a compelling framework for predicting depressive relapse and future research should focus on improving detection of early warning signs reliably. Improving early detection methods for depression is clinically significant, as it would allow for the development of just-in-time interventions.

Identifiants

pubmed: 37956479
pii: S0005-7916(23)00089-7
doi: 10.1016/j.jbtep.2023.101922
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101922

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None.

Auteurs

Natasha A Tonge (NA)

Department of Psychology & Brain Sciences, Washington University in St. Louis, St. Louis, Missouri, USA. Electronic address: ntonge@gmu.edu.

J Philip Miller (JP)

Division of Biostatistics, Washington University in St. Louis, St. Louis, Missouri, USA.

Evan D Kharasch (ED)

Department of Anesthesiology, Duke University School of Medicine, Durham, NC, USA.

Eric J Lenze (EJ)

Department of Psychiatry, Washington University in St. Louis, School of Medicine, St. Louis, Missouri, USA.

Thomas L Rodebaugh (TL)

Department of Psychology & Brain Sciences, Washington University in St. Louis, St. Louis, Missouri, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH